Drug Pipeline

Desloratadine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-08 NCT07632872 Desloratadine as Adjunct Therapy for Rheumatoid Arthritis Phase 2 Recruiting
Active Studies by Phase
Phase 3
1
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07486583 Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients. Chronic Idiopathic Urticaria Not Yet Recruiting
Phase 2
NCT07333716 Desloratadine in Patients With Ulcerative Colitis Ulcerative Colitis (UC) Recruiting
NCT07566351 Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid… Rheumatoid Arthritis Recruiting
NCT07632872 Desloratadine as Adjunct Therapy for Rheumatoid Arthritis Rheumatoid Arthritis (RA) Recruiting
Sponsors Running Desloratadine Trials
Horus University (2) Tanta University (1) Cairo University (1)
Disease Areas
Rheumatoid Arthritis (2) Ulcerative Colitis (1)
Get alerts when Desloratadine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free